What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Omomyc shows its antimetastatic capacity in breast cancer for the first time A Vall d'Hebron study has shown both in vitro and in vivo models that Omomyc, a MYC inhibitor protein, is responsible for halting the progression of metastatic breast cancer. News Almost 20 percent of patients who experience headache during COVID-19 develop chronic daily headache When post-COVID-19 headache lasts for a month, there is a 50% change of it continuing for the next nine months. News Hepatology is the Service with the highest participation in clinical trials of liver diseases in Spain The Hepatology Service is currently participating in 74 clinical trials, of which 50 are commercial. Professionals M. Elena Élez Fernández Elena Élez is an attending phisicyan of the Gastrointestinal Tumors Service of the Medical Oncology Service of the Vall d'Hebron University Hospital. She is currently also Principal Investigator of the Gastrointestinal Tumor Group and Endocrine of VHIO, headed by Josep Tabernero, director of VHIO. Professionals Alex Martínez Martí Dr Martinez is attending physician of the Iung cancer tumor group of Vall d’Hebron University Hospital (HUVH) and also co-investigator of a large number of phase I, phase II and phase III clinical trials and principal investigator of several of them. News Vall d'Hebron and GoodGut are studying the implementation of the first non-invasive diagnostic test for irritable bowel syndrome The use of the new device in the primary care setting will reduce the time it takes for patients with irritable bowel syndrome to be diagnosed and receive optimal treatment, thus improving their quality of life. News Vall d’Hebron enrolls the first patient in a clinical trial designed to treat locally advanced pancreatic cancer with nanoparticles The NoCanTher project has designed a new technology that combines the injection of nanoparticles into the cancer with the application of hyperthermia to locally advanced pancreatic tumors. Now, as a final step, a clinical trial led by Vall d'Hebron Institute of Oncology (VHIO) will be conducted.& News Vall d'Hebron takes part in an analysis of the current status of precision medicine in pediatric oncology in Spain This is a collaborative work of the Spanish Society of Pediatric Hematology and Oncology that aims to promote precision medicine in the national health system. News Play Proa, Vall d’Hebron’s training game on the proper use of antibiotics, is now available to all professionals in Spain and Latin America The programme entails 15 different activities, each with a clinical case that is resolved in under an hour. In each clinical case, actors present a clinical scenario that the user has to solve by means of questionnaires and tests. News Dr Xavier Montalban receives the John Dystel Award for Multiple Sclerosis Research The award is a recognition of his contribution to research on the understanding, treatment and prevention of multiple sclerosis. Pagination Previous page ‹‹ Page 111 Next page ››